文献速递间质性肺疾病

间质性肺疾病的实验与定量成像技术

Experimental and quantitative imaging techniques in interstitial lung disease.
PubMed 文献 · Thorax · 2019-03-18

该综述批判性评价了Ovid、PubMed和TRIP数据库中间质性肺疾病(ILD)新型与定量成像研究,指出基于纹理的肺实质分析可客观量化ILD特征并减少主观性,肺血管容积分析在两项回顾性分析中显示预后价值,超极化气体MRI和PET等功能成像可结合结构与功能信息。多模态定量结构-功能成像有望提供敏感且临床适用的影像标志物,辅助个体化治疗和疗效评估。

要点

  • 基于纹理的定量分析可客观量化ILD特征并减少主观性
  • CT肺血管容积分析在两项回顾性分析中显示预后价值
  • 超极化气体MRI和PET等功能成像可结合结构与功能信息

核心结论

  • 多模态定量肺结构-功能成像有望为ILD提供敏感且临床适用的影像标志物,辅助个体化治疗和疗效评估。

研究设计与样本

  • 综述,批判性评价Ovid、PubMed和TRIP数据库中的ILD新型与定量成像研究。

主要发现

  • 基于纹理的肺实质分析可准确量化多种ILD特征,并有助于区分外周网状影与胸膜及识别蜂窝影的复杂密度模式。
  • CT肺血管容积分析在两项回顾性分析中显示预后价值。
  • PET显示纤维化肺组织中18F-氟脱氧葡萄糖标准摄取值(SUV)高,挑战纤维化区域为代谢不活跃的假设。
  • 结构上看似正常的区域也显示较高SUV,需未来纵向研究评估是否先于宏观结构改变。

临床怎么用

  • 定量纹理分析可减少ILD影像报告主观性,实现更客观的随时间变化测量。
  • 肺血管容积分析可能提示ILD血管改变,即使无显性肺动脉高压。
  • 功能成像(超极化气体MRI、PET)可结合结构与功能信息,辅助评估ILD。
  • 定量评估可客观检测疾病细微变化,辅助抗纤维化治疗疗效评估或早期发现潜在肺毒性药物影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Interstitial lung diseases (ILDs) are a heterogeneous group of conditions, with a wide and complex variety of imaging features. Difficulty in monitoring, treating and exploring novel therapies for these conditions is in part due to the lack of robust, readily available biomarkers. Radiological studies are vital in the assessment and follow-up of ILD, but currently CT analysis in clinical practice is qualitative and therefore somewhat subjective. In this article, we report on the role of novel and quantitative imaging techniques across a range of imaging modalities in ILD and consider how they may be applied in the assessment and understanding of ILD. We critically appraised evidence found from searches of Ovid online, PubMed and the TRIP database for novel and quantitative imaging studies in ILD. Recent studies have explored the capability of texture-based lung parenchymal analysis in accurately quantifying several ILD features. Newer techniques are helping to overcome the challenges inherent to such approaches, in particular distinguishing peripheral reticulation of lung parenchyma from pleura and accurately identifying the complex density patterns that accompany honeycombing. Robust and validated texture-based analysis may remove the subjectivity that is inherent to qualitative reporting and allow greater objective measurements of change over time. In addition to lung parenchymal feature quantification, pulmonary vessel volume analysis on CT has demonstrated prognostic value in two retrospective analyses and may be a sign of vascular changes in ILD which, to date, have been difficult to quantify in the absence of overt pulmonary hypertension. Novel applications of existing imaging techniques, such as hyperpolarised gas MRI and positron emission tomography (PET), show promise in combining structural and functional information. Although structural imaging of lung tissue is inherently challenging in terms of conventional proton MRI techniques, inroads are being made with ultrashort echo time, and dynamic contrast-enhanced MRI may be used for lung perfusion assessment. In addition, inhaled hyperpolarised 129Xenon gas MRI may provide multifunctional imaging metrics, including assessment of ventilation, intra-acinar gas diffusion and alveolar-capillary diffusion. PET has demonstrated high standard uptake values (SUVs) of 18F-fluorodeoxyglucose in fibrosed lung tissue, challenging the assumption that these are 'burned out' and metabolically inactive regions. Regions that appear structurally normal also appear to have higher SUV, warranting further exploration with future longitudinal studies to assess if this precedes future regions of macroscopic structural change. Given the subtleties involved in diagnosing, assessing and predicting future deterioration in many forms of ILD, multimodal quantitative lung structure-function imaging may provide the means of identifying novel, sensitive and clinically applicable imaging markers of disease. Such imaging metrics may provide mechanistic and phenotypic information that can help direct appropriate personalised therapy, can be used to predict outcomes and could potentially be more sensitive and specific than global pulmonary function testing. Quantitative assessment may objectively assess subtle change in character or extent of disease that can assist in efficacy of antifibrotic therapy or detecting early changes of potentially pneumotoxic drugs involved in early intervention studies.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Weatherley ND, Eaden JA, Stewart NJ, et al. Experimental and quantitative imaging techniques in interstitial lung disease. Thorax. 2019. PMID: 30886067. doi:10.1136/thoraxjnl-2018-211779

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。